Cannabis use may alter psychosis severity in methamphetamine users

NCT ID NCT07459270

Not yet recruiting Knowledge-focused Sponsor: Elazığ Mental Health and Diseases Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 90 people hospitalized with methamphetamine-induced psychotic disorder, comparing those who have also used cannabis in their lifetime to those who have not. Researchers will assess psychiatric symptoms, insight, addiction severity, and sleep quality weekly for eight weeks. The goal is to see if cannabis use influences the severity and course of psychosis, and to identify other factors that may play a role.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors understand how cannabis use changes the course of methamphetamine-induced psychosis, leading to better treatment approaches.
What could go wrong: This is an observational study that has not yet started recruiting. It only looks at factors, not a treatment, so it cannot directly improve outcomes. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANNABIS USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cannabis dependence methamphetamine-induced psychosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANNABIS USE METHAMPHETAMINE INDUCED PSYCHOSIS

Contacts and locations

Locations

Elazığ Mental Health and Diseases Hospital

Elâzığ, Elâzığ, 23200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.